Free Trial
OTCMKTS:ADLS

Advanced Life Sciences (ADLS) Stock Price, News & Analysis

$0.01 +0.01 (+9,900.00%)
As of 08/16/2019

About Advanced Life Sciences Stock (OTCMKTS:ADLS)

Key Stats

Today's Range
$0.01
▼
$0.01
50-Day Range
$0.01
▼
$0.01
52-Week Range
$0.0001
▼
$0.01
Volume
1,000 shs
Average Volume
4,868 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Advanced Life Sciences Holdings, Inc. was a biopharmaceutical company focused on developing therapies for serious infectious diseases and other medical conditions. Its research programs centered on novel drug candidates intended to address unmet needs in areas such as respiratory infections and biodefense.

The company’s best-known product candidate was Restanza (cethromycin), an investigational ketolide antibiotic developed for the treatment of community-acquired bacterial pneumonia. Advanced Life Sciences also evaluated cethromycin and related programs for potential use against other infectious diseases, including certain biodefense applications.

Advanced Life Sciences was based in the United States and operated primarily as a development-stage pharmaceutical company rather than a commercial drug manufacturer. Publicly available information about its later operations, current products, geographic reach and leadership is limited, and the company should not be confused with similarly named life sciences businesses.

AI Generated. May Contain Errors.

Receive ADLS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Advanced Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ADLS Stock News Headlines

See More Headlines

ADLS Stock Analysis - Frequently Asked Questions

Advanced Life Sciences' stock was trading at $0.01 at the start of the year. Since then, ADLS stock has increased by 0.0% and is now trading at $0.01.

Company Calendar

Today
10/16/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:ADLS
CIK
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (OTCMKTS:ADLS) was last updated on 8/16/2019 by MarketBeat.com Staff.
From Our Partners